{"result": "(\"entity\"<|>DIABETES MELLITUS<|>EVENT<|>Diabetes Mellitus is a chronic condition that affects how the body processes blood sugar (glucose), leading to episodes of hypoglycemia and other complications.)\n##\n(\"entity\"<|>MEZQUITA-RAYA P<|>PERSON<|>Mezquita-Raya P is an author involved in the research and documentation regarding the evaluation and management of hypoglycemia in diabetes patients.)\n##\n(\"entity\"<|>REYES-GARCÍA R<|>PERSON<|>Reyes-García R is a co-author of the document on the evaluation and management of hypoglycemia in diabetes patients.)\n##\n(\"entity\"<|>MORENO-PÉREZ O<|>PERSON<|>Moreno-Pérez O is a co-author of the document on the evaluation and management of hypoglycemia in diabetes patients.)\n##\n(\"entity\"<|>MUÑOZ-TORRES M<|>PERSON<|>Muñoz-Torres M is a co-author of the document on the evaluation and management of hypoglycemia in diabetes patients.)\n##\n(\"entity\"<|>MERINO-TORRES JF<|>PERSON<|>Merino-Torres JF is a co-author of the document on the evaluation and management of hypoglycemia in diabetes patients.)\n##\n(\"entity\"<|>GORGOJO-MARTÍNEZ JJ<|>PERSON<|>Gorgojo-Martínez JJ is a co-author of the document on the evaluation and management of hypoglycemia in diabetes patients.)\n##\n(\"entity\"<|>AMERICAN DIABETES ASSOCIATION<|>ORGANIZATION<|>The American Diabetes Association is an organization that provides guidelines and reports on diabetes management, including hypoglycemia.)\n##\n(\"entity\"<|>ENDOCRINE SOCIETY<|>ORGANIZATION<|>The Endocrine Society is an organization that collaborates on research and guidelines related to endocrine disorders, including diabetes management.)\n##\n(\"relationship\"<|>MEZQUITA-RAYA P<|>DIABETES MELLITUS<|>Mezquita-Raya P is involved in the research and documentation regarding the management of hypoglycemia in diabetes patients<|>8)\n##\n(\"relationship\"<|>REYES-GARCÍA R<|>DIABETES MELLITUS<|>Reyes-García R is involved in the research and documentation regarding the management of hypoglycemia in diabetes patients<|>8)\n##\n(\"relationship\"<|>MORENO-PÉREZ O<|>DIABETES MELLITUS<|>Moreno-Pérez O is involved in the research and documentation regarding the management of hypoglycemia in diabetes patients<|>8)\n##\n(\"relationship\"<|>MUÑOZ-TORRES M<|>DIABETES MELLITUS<|>Muñoz-Torres M is involved in the research and documentation regarding the management of hypoglycemia in diabetes patients<|>8)\n##\n(\"relationship\"<|>MERINO-TORRES JF<|>DIABETES MELLITUS<|>Merino-Torres JF is involved in the research and documentation regarding the management of hypoglycemia in diabetes patients<|>8)\n##\n(\"relationship\"<|>GORGOJO-MARTÍNEZ JJ<|>DIABETES MELLITUS<|>Gorgojo-Martínez JJ is involved in the research and documentation regarding the management of hypoglycemia in diabetes patients<|>8)\n##\n(\"relationship\"<|>AMERICAN DIABETES ASSOCIATION<|>DIABETES MELLITUS<|>The American Diabetes Association provides guidelines and reports on diabetes management, including hypoglycemia<|>9)\n##\n(\"relationship\"<|>ENDOCRINE SOCIETY<|>DIABETES MELLITUS<|>The Endocrine Society collaborates on research and guidelines related to endocrine disorders, including diabetes management<|>9)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 7,30\n        D.  En menor o igual a 70 mg/dl.                                                                                              Bicarbonato sérico (mEq/l)                    15 a 18           10 a <15              <10               >18\n                                                                                                                                      Cetonuria                                    Positiva           Positiva           Positiva        Baja-mínima\n        COMENTARIO                                                                                                                    Cetonemia-beta hidroxibutirato             3 a 4 mmol/l       4 a 8 mmol/l        >8 mmol/l         <0,6 mmol/l\n                                                                                                                                      (rango normal < 0,6 mmol/l)\n        La hipoglucemia es el principal factor limitante en el manejo glucémico de la DM1 y la                                        Osmolaridad plasmática efectiva\n        DM2.    En   pacientes     con    diabetes,    la  hipoglucemia       se   define   como     cualquier     episodio           (mOsm/kg)                                    Variable           Variable           Variable            >320\n        de concentración plasmática             de  glucosa anormalmente            baja (con    o sin síntomas)       en   el\n        que el individuo se       expone     a  un daño. El valor       por debajo del cual se         define   la hipoglu-           Anion gap                                       >10                >12                >12             Variable\n        cemia en pacientes con diabetes, 70 mg/dl, es más alto que el empleado para diagnos-                                          Nivel de consciencia                           Alerta            Alerta/           Estupor/           Estupor/\n        ticar la hipoglucemia        en pacientes      no diabéticos      (menor de 55 mg/dl), y no está exento                                                                                     somnoliento           coma               coma\n        de debate. Se define tomando como base el umbral                      glucémico normal para la secreción                    Referencias:\n        hormonal contrarreguladora. Debido a que muchas personas con diabetes muestran                                              • Mezquita-Raya P, Reyes-García R, Moreno-Pérez O, Muñoz-Torres M, Merino-Torres JF, Gorgojo-Martínez JJ, et al. Diabetes Mellitus\n        respuestas     contrarreguladoras         deficientes    a  la  hipoglucemia       y/o  experimentan        falta  de         Working Group of the Spanish Society of Endocrinology and Nutrition (SEEN). Documento de posicionamiento: evaluación y manejo\n                                                                                                                                      de la hipoglucemia en el paciente con diabetes mellitus. Endocrinol Nutr. 2013;60(9):517.e1-18.\n        conciencia de hipoglucemia, una medición de glucosa con un nivel inferior a 70 mg/dl                                        • Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, et al. Hypoglycemia and diabetes: a report of a workgroup of the\n        (3,9 mmol/l) se considera clínicamente importante, independientemente de la gravedad de                                       American Diabetes Association and the Endocrine Society. Diabetes Care. 2013;36(5)1384-95.\n        los síntomas de hipoglucemia aguda.\n          En la práctica, la hipoglucemia se clasifica por sus consecuencias clínicas:                                          32  Paciente con diabetes mellitus que acude a urgencias obnubilado, presentando\n          •  Hipoglucemia grave: requiere para su recuperación de la ayuda de otra persona que                                      los siguientes valores: glucemia, 340 mg/dl; pH, 7,07; sodio, 136 mEq/l; potasio,\n             administre los hidratos de carbono, glucagón u otras medidas. Aunque no se disponga                                    4-5 mEq/l, y bicarbonato, 11,2 mmol/l con cetonuria. En relación con el tratamiento\n             de medición de glucemia, la recuperación neurológica atribuible a la restauración de la                                y su evolución, ¿cuál de los siguientes enunciados no es correcto?\n             concentración normal de glucosa se considera evidencia suficiente.                                                     A. En este contexto clínico y una vez resuelto el cuadro es conveniente parar la insulina\n          •  Hipoglucemia documentada sintomática:                 los síntomas típicos de hipoglucemia van                             intravenosa antes de continuar con la subcutánea.\n             acompañados por una determinación de glucosa en plasma inferior a 70 mg/dl.                                            B. Proporcionaremos ya aporte de glucosa intravenosa (p. ej., al 5%) cuando la glucemia sea\n          •  Hipoglucemia asintomática: determinación de glucosa en plasma inferior a 70 mg/dl                                          inferior a 250 mg/dl.\n             sin síntomas acompañantes.                                                                                             C. El edema cerebral es raro, pero ocurre con más frecuencia en niños.\n          •  Hipoglucemia sintomática probable: síntomas típicos de hipoglucemia que no se acom-                                    D.  La cetoacidosis se resuelve a medida que la insulina reduce la lipólisis.\n             pañan de una determinación de glucosa plasm\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}